Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study

Diabetes Care. 2001 Jun;24(6):1053-9. doi: 10.2337/diacare.24.6.1053.

Abstract

Objective: Subjects with type 1 diabetes are at high risk for many long-term complications, including early mortality and coronary artery disease (CAD). Few data are available on which to base goal levels for two major risk factors, namely blood pressure and lipid/lipoproteins. The objective of this study was to determine at which levels of LDL and HDL cholesterol, triglycerides, and blood pressure the relative risks of type 1 diabetic complications increase significantly.

Research design and methods: Observational prospective study of 589 patients with childhood-onset type 1 diabetes (<17 years) aged > or =18 years at baseline; 10-year incidence of mortality, CAD, lower-extremity arterial disease, proliferative retinopathy, distal symmetric polyneuropathy, and overt nephropathy. Relative risks were determined using traditional groupings of blood pressure and lipid/lipoproteins, measured at baseline, using the lowest groupings (<100 mg/dl [2.6 mmol/l] LDL cholesterol, <45 mg/dl [1.1 mmol/l] HDL cholesterol, <100 mg/dl [1.1 mmol/l] triglycerides, <110 mmHg systolic blood pressure, and <80 mmHg diastolic blood pressure) as reference. Adjustments for age, sex, and glycemic control were examined.

Results: Driven mainly by strong relationships (RR range 1.8-12.1) with mortality, CAD, and overt nephropathy, suggested goal levels are as follows: LDL cholesterol <100 mg/dl (2.6 mmol/l), HDL cholesterol >45 mg/dl (1.1 mmol/l), triglycerides <150 mg/dl (1.7 mmol/l), systolic blood pressure <120 mmHg, and diastolic blood pressure <80 mmHG: Age, sex, and glycemic control had little influence on these goals.

Conclusions: Although observational in nature, these data strongly support the case for vigorous control of lipid levels and blood pressure in patients with type 1 diabetes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Blood Pressure / physiology*
  • Cholesterol, HDL / blood
  • Cohort Studies
  • Coronary Disease / epidemiology*
  • Coronary Disease / mortality
  • Diabetes Mellitus, Type 1 / mortality
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Diabetes Mellitus, Type 1 / therapy*
  • Diabetic Angiopathies / epidemiology*
  • Diabetic Angiopathies / mortality
  • Diabetic Nephropathies / epidemiology
  • Diabetic Nephropathies / mortality
  • Diabetic Neuropathies / epidemiology*
  • Diabetic Neuropathies / mortality
  • Diabetic Retinopathy / epidemiology*
  • Diabetic Retinopathy / mortality
  • Diastole
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Incidence
  • Male
  • Pennsylvania / epidemiology
  • Proportional Hazards Models
  • Risk
  • Risk Factors
  • Systole
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Glycated Hemoglobin A
  • Triglycerides